PATH-01. MGMT METHYLATION CUTOFF VALUE IN QUANTITATIVE ANALYSIS RELATED TO PROGNOSIS OF NEWLY DIAGNOSED GLIOBLASTOMA

BACKGROUND: MGMT promoter methylation is an important biomarker related to glioblastoma therapeutic response and prognosis. There are qualitative and quantitative methods as assays for MGMT methylation. Although the qualitative method is common, there is a disadvantage that low or high methylation c...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Adachi, Jun-ichi, Shirahata, Mitsuaki, Suzuki, Tomonari, Mishima, Kazuhiko, Nishikawa, Ryo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2019
Konular:
Molecular Pathology and Classification - Adult and Pediatric
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847915/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.597
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller